• Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Transition Therapeutics Inc

+ Add to Watchlist

TTH:CN

8.1000 CAD 0.1000 1.25%

As of 13:21:00 ET on 08/29/2014.

Snapshot for Transition Therapeutics Inc (TTH)

Open: 8.0500 Day's Range: 8.0500 - 8.1000 Volume: 411
Previous Close: 8.0000 52wk Range: 4.0400 - 9.2500 1-Yr Rtn: +80.00%

Stock Chart for TTH

No chart data available.
  • TTH:CN 8.1000
  • 1D
  • 1M
  • 1Y
8.0000
Interactive TTH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TTH

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) -
Relative P/E vs. SPTSX -
Earnings Per Share (CAD) (ttm) -0.1300
Est. EPS (CAD) (06/2014) -0.5970
Est. PEG Ratio -
Market Cap (M CAD) 285.98
Shares Outstanding (M) 35.31
30 Day Average Volume 2,779
Price/Book (mrq) 4.8727
Price/Sale (ttm) 30.5431
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/11/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TTH

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for TTH

Transition Therapeutics Inc. is a biopharmaceutical company focused on developing novel therapeutics in order to address global medical needs in large disease indications, including Alzheimer's disease and diabetes.

Tony F CruzChairman/CEONicole Rusaw GeorgeChief Financial Officer
Carl DamianiChief Operating OfficerAleksandra PastrakVP:Clinical Dev/Medical Ofcr
More Company Profile & Key Executives for TTH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil